Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma
Jong-Yun Woo, Seung Ho Yang, Youn Soo Lee, Su Youn Lee, Jeana Kim, Yong Kil Hong
J Korean Neurosurg Soc. 2015;58(5):426-431.   Published online 2015 Nov 30     DOI: https://doi.org/10.3340/jkns.2015.58.5.426
Citations to this article as recorded by Crossref logo
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Cem Simsek, Ece Esin, Suayib Yalcin
Journal of Oncology.2019; 2019: 1.     CrossRef
Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation
Se-Hyuk Kim, Heon Yoo, Jong Hee Chang, Chae-Yong Kim, Dong Sup Chung, Se Hoon Kim, Sung-Hae Park, Youn Soo Lee, Seung Ho Yang
Journal of Korean Medical Science.2018;[Epub]     CrossRef
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma
Zhengqiu Zhou, Tracy A. Howard, John L. Villano
Cancer Chemotherapy and Pharmacology.2017; 80(5): 1043.     CrossRef